146 related articles for article (PubMed ID: 26209355)
1. Monocytic MDSCs regulate macrophage-mediated xenogenic cytotoxicity.
Maeda A; Eguchi H; Nakahata K; Lo PC; Yamanaka K; Kawamura T; Matsuura R; Sakai R; Asada M; Okuyama H; Miyagawa S
Transpl Immunol; 2015 Oct; 33(2):140-5. PubMed ID: 26209355
[TBL] [Abstract][Full Text] [Related]
2. Monocytic suppressor cells derived from human peripheral blood suppress xenogenic immune reactions.
Maeda A; Kawamura T; Ueno T; Usui N; Miyagawa S
Xenotransplantation; 2014; 21(1):46-56. PubMed ID: 24372857
[TBL] [Abstract][Full Text] [Related]
3. Human regulatory macrophages are potent in suppression of the xenoimmune response via indoleamine-2,3-dioxygenase-involved mechanism(s).
Guo F; Hu M; Huang D; Zhao Y; Heng B; Guillemin G; Lim CK; Hawthorne WJ; Yi S
Xenotransplantation; 2017 Sep; 24(5):. PubMed ID: 28771838
[TBL] [Abstract][Full Text] [Related]
4. Monocytic suppressor cells derived from peripheral blood suppress xenogenic natural killer cell lysis.
Maeda A; Kawamura T; Nakahata K; Ueno T; Usui N; Eguchi H; Miyagawa S
Transplant Proc; 2014 May; 46(4):1254-5. PubMed ID: 24815174
[TBL] [Abstract][Full Text] [Related]
5. Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.
Yu J; Du W; Yan F; Wang Y; Li H; Cao S; Yu W; Shen C; Liu J; Ren X
J Immunol; 2013 Apr; 190(7):3783-97. PubMed ID: 23440412
[TBL] [Abstract][Full Text] [Related]
6. Tumor-associated GM-CSF overexpression induces immunoinhibitory molecules via STAT3 in myeloid-suppressor cells infiltrating liver metastases.
Thorn M; Guha P; Cunetta M; Espat NJ; Miller G; Junghans RP; Katz SC
Cancer Gene Ther; 2016 Jun; 23(6):188-98. PubMed ID: 27199222
[TBL] [Abstract][Full Text] [Related]
7. Immuno-regulatory function of indoleamine 2,3 dioxygenase through modulation of innate immune responses.
Poormasjedi-Meibod MS; Jalili RB; Hosseini-Tabatabaei A; Hartwell R; Ghahary A
PLoS One; 2013; 8(8):e71044. PubMed ID: 23940687
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte colony-stimulating factor-induced immature myeloid cells inhibit acute graft-versus-host disease lethality through an indoleamine dioxygenase-independent mechanism.
Joo YD; Lee SM; Lee SW; Lee WS; Lee SM; Park JK; Choi IW; Park SG; Choi I; Seo SK
Immunology; 2009 Sep; 128(1 Suppl):e632-40. PubMed ID: 19740324
[TBL] [Abstract][Full Text] [Related]
9. A Strategy for Suppressing Macrophage-mediated Rejection in Xenotransplantation.
Maeda A; Lo PC; Sakai R; Noguchi Y; Kodama T; Yoneyama T; Toyama C; Wang HT; Esquivel E; Jiaravuthisan P; Choi TV; Takakura C; Eguchi H; Tazuke Y; Watanabe M; Nagashima H; Okuyama H; Miyagawa S
Transplantation; 2020 Apr; 104(4):675-681. PubMed ID: 31634326
[TBL] [Abstract][Full Text] [Related]
10. Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner.
Holmgaard RB; Zamarin D; Li Y; Gasmi B; Munn DH; Allison JP; Merghoub T; Wolchok JD
Cell Rep; 2015 Oct; 13(2):412-24. PubMed ID: 26411680
[TBL] [Abstract][Full Text] [Related]
11. Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.
Parker KH; Beury DW; Ostrand-Rosenberg S
Adv Cancer Res; 2015; 128():95-139. PubMed ID: 26216631
[TBL] [Abstract][Full Text] [Related]
12. Noncanonical NF-κB activation mediates STAT3-stimulated IDO upregulation in myeloid-derived suppressor cells in breast cancer.
Yu J; Wang Y; Yan F; Zhang P; Li H; Zhao H; Yan C; Yan F; Ren X
J Immunol; 2014 Sep; 193(5):2574-86. PubMed ID: 25063873
[TBL] [Abstract][Full Text] [Related]
13. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
[TBL] [Abstract][Full Text] [Related]
14. Human CD31 on porcine cells suppress xenogeneic neutrophil-mediated cytotoxicity via the inhibition of NETosis.
Wang HT; Maeda A; Sakai R; Lo PC; Takakura C; Jiaravuthisan P; Mod Shabri A; Matsuura R; Kodama T; Hiwatashi S; Eguchi H; Okuyama H; Miyagawa S
Xenotransplantation; 2018 Sep; 25(5):e12396. PubMed ID: 29635708
[TBL] [Abstract][Full Text] [Related]
15. The calcineurin-NFAT axis controls allograft immunity in myeloid-derived suppressor cells through reprogramming T cell differentiation.
Wang X; Bi Y; Xue L; Liao J; Chen X; Lu Y; Zhang Z; Wang J; Liu H; Yang H; Liu G
Mol Cell Biol; 2015 Feb; 35(3):598-609. PubMed ID: 25452304
[TBL] [Abstract][Full Text] [Related]
16. Human CD200 suppresses macrophage-mediated xenogeneic cytotoxicity and phagocytosis.
Sakai R; Maeda A; Choi TV; Lo PC; Jiaravuthisan P; Shabri AM; Wang HT; Matsuura R; Kodama T; Eguchi H; Okuyama H; Miyagawa S
Surg Today; 2018 Jan; 48(1):119-126. PubMed ID: 28573328
[TBL] [Abstract][Full Text] [Related]
17. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs.
Jitschin R; Braun M; Büttner M; Dettmer-Wilde K; Bricks J; Berger J; Eckart MJ; Krause SW; Oefner PJ; Le Blanc K; Mackensen A; Mougiakakos D
Blood; 2014 Jul; 124(5):750-60. PubMed ID: 24850760
[TBL] [Abstract][Full Text] [Related]
18. Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors.
Holmgaard RB; Zamarin D; Lesokhin A; Merghoub T; Wolchok JD
EBioMedicine; 2016 Apr; 6():50-58. PubMed ID: 27211548
[TBL] [Abstract][Full Text] [Related]
19. Serum inhibits the immunosuppressive function of myeloid-derived suppressor cells isolated from 4T1 tumor-bearing mice.
Hamilton MJ; Banáth JP; Lam V; Lepard NE; Krystal G; Bennewith KL
Cancer Immunol Immunother; 2012 May; 61(5):643-54. PubMed ID: 22021068
[TBL] [Abstract][Full Text] [Related]
20. HLA-G promotes myeloid-derived suppressor cell accumulation and suppressive activity during human pregnancy through engagement of the receptor ILT4.
Köstlin N; Ostermeir AL; Spring B; Schwarz J; Marmé A; Walter CB; Poets CF; Gille C
Eur J Immunol; 2017 Feb; 47(2):374-384. PubMed ID: 27859042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
